Scientific review of phase I protocols with novel dose-escalation designs: How much information is needed? Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Clinical Trials, Phase I as Topic
  • Maximum Tolerated Dose
  • Medical Oncology
  • Research Design

publication date

  • July 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4962621

Digital Object Identifier (DOI)

  • 10.1200/JCO.2014.59.8466

PubMed ID

  • 25940721

Additional Document Info

start page

  • 2221

end page

  • 5

volume

  • 33

number

  • 19